Rocca Walter A, Bower James H, Ahlskog J Eric, Elbaz Alexis, Grossardt Brandon R, McDonnell Shannon K, Schaid Daniel J, Maraganore Demetrius M
Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic College of Medicine, 200 First St SW, Rochester, MN 55905, USA.
Arch Neurol. 2007 Oct;64(10):1458-64. doi: 10.1001/archneur.64.10.1458.
The evidence for increased risk of dementia in relatives of patients with Parkinson disease (PD) remains conflicting.
To study the risk of cognitive impairment or dementia in first-degree relatives of patients with PD.
DESIGN, SETTING, AND PARTICIPANTS: We conducted a historical cohort study of 1019 first-degree relatives of 162 patients with PD and of 858 relatives of 147 matched controls representative of the population of Olmsted County, Minnesota. In addition, we studied 2716 first-degree relatives of 411 patients with PD referred to Mayo Clinic.
We administered via telephone a cognitive test directly to relatives or a dementia questionnaire to proxies. For relatives reported by proxies to have dementia, we obtained copies of their medical records to confirm the diagnosis. We also obtained dementia information from a medical records-linkage system.
In the overall population-based sample, the risk of cognitive impairment or dementia was increased in relatives of patients with PD compared with relatives of controls (hazard ratio, 1.37; 95% confidence interval, 1.03-1.81; P = .03) and was particularly increased in relatives of patients with onset of PD at age 66 years or younger (youngest tertile; hazard ratio, 1.73; 95% confidence interval, 1.21-2.46; P = .003). The findings were consistent in several sensitivity analyses. In the referral-based sample, the risk of cognitive impairment or dementia in relatives increased with younger age at onset of PD but did not vary by other clinical characteristics.
Cognitive impairment or dementia may share familial susceptibility factors with PD (genetic or nongenetic).
帕金森病(PD)患者亲属患痴呆症风险增加的证据仍存在矛盾。
研究PD患者一级亲属发生认知障碍或痴呆的风险。
设计、地点和参与者:我们对162例PD患者的1019名一级亲属以及明尼苏达州奥尔姆斯特德县具有代表性的147名匹配对照的858名亲属进行了一项历史性队列研究。此外,我们还研究了转诊至梅奥诊所的411例PD患者的2716名一级亲属。
我们通过电话直接对亲属进行认知测试,或向代理人发放痴呆问卷。对于代理人报告患有痴呆症的亲属,我们获取其病历副本以确诊。我们还从病历关联系统中获取痴呆症信息。
在基于总体人群的样本中,与对照组亲属相比,PD患者亲属发生认知障碍或痴呆的风险增加(风险比,1.37;95%置信区间,1.03 - 1.81;P = 0.03),且在66岁及以下发病的PD患者亲属中风险尤其增加(最低三分位数;风险比,1.73;95%置信区间,1.21 - 2.46;P = 0.003)。在多项敏感性分析中结果一致。在基于转诊的样本中,亲属发生认知障碍或痴呆的风险随PD发病年龄降低而增加,但不受其他临床特征影响。
认知障碍或痴呆可能与PD(遗传或非遗传)共享家族易感性因素。